Abstract
A capture immunoglobulin M (IgM) enzyme immunoassay was developed to diagnose La Crosse virus infections by the detection of specific IgM in acutephase serum specimens. IgM was detected by the capture IgM system in the serum of 24 of 29 (83%) of the patients studied. In comparison, IgM was detected in 19 of 29 (66%) of the patients by an indirect immunofluorescence technique. Specific IgM was detected in 83% (20 of 24) of patient serum specimens by day 3 after the onset of clinical symptoms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
